Trius Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Trius Therapeutics, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SIVEXTRO. The owner is based in San Diego, CA.
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
Trius Therapeutics, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Trius Therapeutics, Inc. have?
Trius Therapeutics, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 3 cancelled.
What trademark classes does Trius Therapeutics, Inc. file in?
Trius Therapeutics, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Trius Therapeutics, Inc.'s most well-known trademarks?
Trius Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as SIVEXTRO. These are among 1 currently registered trademark in the portfolio.
What is Trius Therapeutics, Inc.'s trademark registration success rate?
Trius Therapeutics, Inc. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.